Literature DB >> 14977467

Proton magnetic resonance spectroscopy of the frontal lobe and cerebellar vermis in children with a mood disorder and a familial risk for bipolar disorders.

Kim M Cecil1, Melissa P DelBello, Michele C Sellars, Stephen M Strakowski.   

Abstract

OBJECTIVE: Few studies have examined the neurochemical abnormalities that might be associated with pediatric bipolar disorder. The aim of this study was to use magnetic resonance spectroscopy to evaluate several brain regions implicated in bipolar disorder in children with a mood disorder and a familial risk for bipolar disorder. We hypothesized that these children would exhibit neurochemical differences compared with healthy children of parents without a psychiatric disorder. Specifically, decreased N-acetylaspartate (NAA) and creatine and phosphocreatine (Cr) of the prefrontal cortex and cerebellar vermis would reflect impairments in neuronal function and cellular metabolism, and elevated myo-inositol (mI) would reflect impaired phosphoinositide metabolism, potentially representing early markers of neurophysiologic changes that might underlie the development of bipolar disorder.
METHODS: Children with a mood disorder and at least one parent with bipolar disorder (n = 9) and healthy children (n = 10) group matched for age (8-12 years), race, sex, education, and Tanner stage were evaluated using the Washington University in St. Louis Kiddie Schedule for Affective Disorders and Schizophrenia. Proton magnetic resonance spectroscopy was acquired using 8-cc volumes within the frontal cortex, frontal white matter, and the cerebellar vermis. Metabolite ratios (NAA/Cr, cholines (Cho)/Cr, mI/Cr, NAA/Cho, NAA/mI, and Cho/mI) and concentrations (NAA, Cr, Cho, and mI) were calculated and compared between groups.
RESULTS: The trend in concentration levels of NAA and Cr was approximately 8% lower for children with a mood disorder than healthy children within the cerebellar vermis. The frontal cortex in children with a mood disorder revealed elevated mI concentration levels, approximately 16% increased, compared with healthy children.
CONCLUSIONS: Similar to findings in adults with bipolar disorders, neurochemical abnormalities within the frontal cortex and the cerebellar vermis were present in this preliminary comparison of children with a mood disorder and a familial risk for bipolar disorder. Larger sample sizes are needed to replicate these findings.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14977467     DOI: 10.1089/104454603322724931

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN: 1044-5463            Impact factor:   2.576


  42 in total

1.  Association of Myoinositol Transporters with Schizophrenia and Bipolar Disorder: Evidence from Human and Animal Studies.

Authors:  Marquis P Vawter; Abdul Rezzak Hamzeh; Edgar Muradyan; Olivier Civelli; Geoffrey W Abbott; Amal Alachkar
Journal:  Mol Neuropsychiatry       Date:  2019-08-08

2.  Prospective neurochemical characterization of child offspring of parents with bipolar disorder.

Authors:  Manpreet K Singh; Booil Jo; Nancy E Adleman; Meghan Howe; Layla Bararpour; Ryan G Kelley; Daniel Spielman; Kiki D Chang
Journal:  Psychiatry Res       Date:  2013-09-09       Impact factor: 3.222

3.  Alterations of the cerebellum and basal ganglia in bipolar disorder mood states detected by quantitative T1ρ mapping.

Authors:  Casey P Johnson; Gary E Christensen; Jess G Fiedorowicz; Merry Mani; Joseph J Shaffer; Vincent A Magnotta; John A Wemmie
Journal:  Bipolar Disord       Date:  2018-01-07       Impact factor: 6.744

4.  Aberrant cerebellar connectivity in bipolar disorder with psychosis.

Authors:  Ann K Shinn; Youkyung S Roh; Caitlin T Ravichandran; Justin T Baker; Dost Öngür; Bruce M Cohen
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2017-07

5.  Effect of divalproex on brain morphometry, chemistry, and function in youth at high-risk for bipolar disorder: a pilot study.

Authors:  Kiki Chang; Asya Karchemskiy; Ryan Kelley; Meghan Howe; Amy Garrett; Nancy Adleman; Allan Reiss
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-02       Impact factor: 2.576

6.  Randomized double-blind placebo-controlled trial of lithium in youths with severe mood dysregulation.

Authors:  Daniel P Dickstein; Kenneth E Towbin; Jan Willem Van Der Veen; Brendan A Rich; Melissa A Brotman; Lisa Knopf; Laura Onelio; Daniel S Pine; Ellen Leibenluft
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-02       Impact factor: 2.576

Review 7.  A review of MR spectroscopy studies of pediatric bipolar disorder.

Authors:  D G Kondo; T L Hellem; X-F Shi; Y H Sung; A P Prescot; T S Kim; R S Huber; L N Forrest; P F Renshaw
Journal:  AJNR Am J Neuroradiol       Date:  2014-02-20       Impact factor: 3.825

8.  Neurometabolite effects of response to quetiapine and placebo in adolescents with bipolar depression.

Authors:  Kiki Chang; Melissa Delbello; Wen-Jang Chu; Amy Garrett; Ryan Kelley; Neil Mills; Meghan Howe; Holly Bryan; Cal Adler; Jim Eliassen; Daniel Spielman; Stephen M Strakowski
Journal:  J Child Adolesc Psychopharmacol       Date:  2012-07-31       Impact factor: 2.576

9.  A comparison of affected and unaffected relatives of patients with bipolar disorder using proton magnetic resonance spectroscopy.

Authors:  Tomas Hajek; Denise Bernier; Claire Slaney; Lukas Propper; Matthias Schmidt; Normand Carrey; Glenda MacQueen; Anne Duffy; Martin Alda
Journal:  J Psychiatry Neurosci       Date:  2008-11       Impact factor: 6.186

Review 10.  The neurotrophic and neuroprotective effects of psychotropic agents.

Authors:  Joshua Hunsberger; Daniel R Austin; Ioline D Henter; Guang Chen
Journal:  Dialogues Clin Neurosci       Date:  2009       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.